Device: Desktop
|
X
Home
Innovation
Mission
Latest News
Meet Us
Management Team
Corporate Team
Key R&D Team
Board of Directors
Scientific Advisory Board
Science
Molecular Target
Mechanism of Action
Aelis Farma's Targets
Pipeline
AEF0117
AEF0217
New CB
1
-SSi
Partners
News
Contact
Investors
Menu
Home
Meet Us
Science
Pipeline
Partners
News
Contact
Investors
All articles
Nov 18, 2024
Aelis Farma announces the positive results of its clinical Phase 1/2 Study with AEF0217 in young adults with Down syndrome
Press release
Webinar summary